Business Description
IMCD NV
ISIN : NL0010801007
Compare
Compare
Traded in other countries / regions
IMCD.Netherlands0QVU.UKIMCDY.USAINX.GermanyIMCD.AustriaIMCD.Mexico IPO Date
2014-07-02Description
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments; EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.71 | |||||
| Debt-to-EBITDA | 2.15 | |||||
| Interest Coverage | 6.29 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.94 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.9 | |||||
| 3-Year EBITDA Growth Rate | 27.6 | |||||
| 3-Year EPS without NRI Growth Rate | 27.3 | |||||
| 3-Year FCF Growth Rate | 19.2 | |||||
| 3-Year Book Growth Rate | 11.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 15.44 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.44 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.81 | |||||
| 9-Day RSI | 40.13 | |||||
| 14-Day RSI | 40.7 | |||||
| 6-1 Month Momentum % | 5.92 | |||||
| 12-1 Month Momentum % | 6.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.38 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 66.57 | |||||
| Days Sales Outstanding | 65.03 | |||||
| Days Payable | 50.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.63 | |||||
| Dividend Payout Ratio | 0.45 | |||||
| 3-Year Dividend Growth Rate | 38.1 | |||||
| Forward Dividend Yield % | 1.63 | |||||
| 5-Year Yield-on-Cost % | 5.85 | |||||
| Shareholder Yield % | -2.75 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.25 | |||||
| Operating Margin % | 9.02 | |||||
| Net Margin % | 6.19 | |||||
| FCF Margin % | 7.96 | |||||
| ROE % | 16.42 | |||||
| ROA % | 6.69 | |||||
| ROIC % | 9.04 | |||||
| ROC (Joel Greenblatt) % | 112.95 | |||||
| ROCE % | 14.97 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.43 | |||||
| Forward PE Ratio | 20.13 | |||||
| PE Ratio without NRI | 28.43 | |||||
| Shiller PE Ratio | 49.74 | |||||
| Price-to-Owner-Earnings | 14.93 | |||||
| PEG Ratio | 1.2 | |||||
| PS Ratio | 1.76 | |||||
| PB Ratio | 4.56 | |||||
| Price-to-Free-Cash-Flow | 22.09 | |||||
| Price-to-Operating-Cash-Flow | 20.21 | |||||
| EV-to-EBIT | 20.7 | |||||
| EV-to-Forward-EBIT | 15.46 | |||||
| EV-to-EBITDA | 16.12 | |||||
| EV-to-Forward-EBITDA | 14.56 | |||||
| EV-to-Revenue | 2.05 | |||||
| EV-to-Forward-Revenue | 1.83 | |||||
| EV-to-FCF | 25.73 | |||||
| Price-to-Projected-FCF | 1.85 | |||||
| Price-to-Median-PS-Value | 1.15 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.27 | |||||
| Earnings Yield (Greenblatt) % | 4.83 | |||||
| FCF Yield % | 4.36 | |||||
| Forward Rate of Return (Yacktman) % | 22.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IMCD NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4,540.074 | ||
| EPS (TTM) (€) | 4.93 | ||
| Beta | 1.69 | ||
| Volatility % | 39.9 | ||
| 14-Day RSI | 40.7 | ||
| 14-Day ATR (€) | 2.203887 | ||
| 20-Day SMA (€) | 141.6825 | ||
| 12-1 Month Momentum % | 6.3 | ||
| 52-Week Range (€) | 127 - 165.1 | ||
| Shares Outstanding (Mil) | 59.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IMCD NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IMCD NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
IMCD NV Frequently Asked Questions
What is IMCD NV(FRA:INX)'s stock price today?
The current price of FRA:INX is €137.25. The 52 week high of FRA:INX is €165.10 and 52 week low is €127.00.
When is next earnings date of IMCD NV(FRA:INX)?
The next earnings date of IMCD NV(FRA:INX) is .
Does IMCD NV(FRA:INX) pay dividends? If so, how much?
The Dividend Yield %  of IMCD NV(FRA:INX) is 1.63% (As of Today), Highest Dividend Payout Ratio of IMCD NV(FRA:INX) was 0.5. The lowest was 0.15. And the median was 0.32. The  Forward Dividend Yield % of IMCD NV(FRA:INX) is 1.63%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers